QCG
BDSI

Quadrant Capital Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Quadrant Capital Group’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-171
Closed -$1K – 2806
2021
Q3 		$1K Hold
171
– – ﹤0.01% 2470
2021
Q2 		$1K Buy
171
+130
+317% +$459 ﹤0.01% 2384
2021
Q1 		$0 Hold
41
– – ﹤0.01% 2520
2020
Q4 		$0 Buy
+41
New +$158 ﹤0.01% 2445

Other funds holding BDSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quadrant Capital Group's BDSI Position: Q4 2021 in Review

Quadrant Capital Group sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2021, closing a stake of 171 shares — an estimated $1K sold.

Quadrant Capital Group first reported a position in BDSI in Q4 2020 and held it in 4 quarters. The position peaked at $1K in Q3 2021. 156 funds tracked by Wall St. Rank hold BDSI as of Q4 2021.

  • Quadrant Capital Group reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2021 after selling out during the quarter.
  • Quadrant Capital Group sold 171 BioDelivery Sciences International, Inc. shares in Q4 2021, an estimated $1K.
  • Quadrant Capital Group first reported a position in BioDelivery Sciences International, Inc. in Q4 2020 and held it in 4 quarters.
  • Quadrant Capital Group's BioDelivery Sciences International, Inc. position peaked at $1K in Q3 2021.
  • 156 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2021.

Based on Quadrant Capital Group's 13F filing for Q4 2021, filed 1 Feb 2022.